ALV Form 4: Kevin Fox Discloses Performance and Time-Based RSU Awards
Rhea-AI Filing Summary
Kevin Fox, President, Autoliv Americas, reported acquisitions of restricted stock units in Autoliv Inc. (ALV) on 09/23/2025. The Form 4 shows grant entries for performance-based and time-based restricted stock units (RSUs). The filing lists 11.993 performance-based RSUs from the 2023 grant, 8.018 performance-based RSUs from the 2024 grant, and three time-based RSU tranches of 3.9931, 6.2623, and 6.8944 shares that vest on 02/15/2026, 02/20/2027 and 02/21/2028 respectively. The filing explains that each RSU converts to one share of common stock and that dividend equivalents accrued as additional RSUs are included. The performance-based RSUs vest after completion of multi-year performance periods and committee certification of achievement.
Positive
- Filed timely Section 16 Form 4 disclosing equity awards for the reporting officer on 09/23/2025
- Detailed vesting dates and award types are provided, including performance-based RSUs with specified performance periods and time-based RSU vesting dates
- Dividend equivalent treatment is disclosed as additional RSUs subject to the same vesting schedules
Negative
- None.
Insights
TL;DR: Officer received a mix of performance and time-based RSU awards on 09/23/2025; vesting tied to multi-year performance and scheduled dates.
The filing documents non-derivative equity awards to a named officer rather than open-market trades. The performance-based RSUs reference distinct performance periods ending December 31, 2025 and 2026 with vesting contingent on committee certification, which is standard for senior executive compensation. Time-based RSUs have clear vesting dates in 2026–2028. From a governance perspective, the filing provides transparency on timing and nature of awards but does not disclose target performance metrics or the maximum payout adjustments. This is a routine Section 16 disclosure of grants rather than a market transaction.
TL;DR: The report shows incremental equity grants totaling 37.1608 RSUs across performance and service-based awards, recorded as acquisitions.
Line-item details identify 11.993 RSUs (2023 performance grant), 8.018 RSUs (2024 performance grant), and three restricted stock unit tranches of 3.9931, 6.2623, and 6.8944 with vesting in 2026–2028. Dividend equivalents are credited as additional RSUs per the award agreement. The disclosure is complete for quantities and vesting dates but lacks the underlying performance targets and potential payout ranges, which limits assessment of grant generosity or alignment with shareholder outcomes.